Answers are grounded in this paper and cite their sources.
Children and adolescents living with Type 1 Diabetes (T1DM) in India face multitude of challenges including lack of free supply of insulin, syringes, glucose measuring devices and strips, lack of structured diabetes education and counselling, and inadequately trained health care professionals. 1 Multiple daily injections of insulin, self-monitoring of blood glucose, prevention of acute and chronic complications, structured diabetes education, psychosocial support, and safe disposal of sharps are essential components in the management of T1DM. 1 Absence or disruption of standard care affects the physical and mental well-being of these children.T1DM affects approximately1¢2 million children and adolescents worldwide in the age group of 0 À 19 years, with 149,500 new cases being diagnosed every year. 2 Data from International Diabetes Federation (IDF) Diabetes Atlas 2021 indicates that India has the world's highest number of children and adolescents suffering from T1DM. 2 But in the absence of a nationwide T1DM registry, it is difficult to estimate exact numbers.Government of India took initiative to launch the National Programme for Prevention and Control of Cancer, Diabetes, Cardiovascular Diseases and Stroke (NPCDCS) in the year 2008.3 This program is adult-centric with no initiatives to address juvenile non-communicable diseases (NCD).3 A few non-government organizations and pharmaceutical companies offer some support for T1DM in India.4 However, these are all isolated piece meal initiatives.A recent study conducted in a tertiary health care facility in West Bengal, India found that mean glycated hemoglobin (HbA1c) level was 9¢1 § 2¢36.5 A structured national health care policy is the need of the hour.This could be part of a bigger overarching health care program such as juvenile NCD program.Extensive literature search revealed that in developing countries, there is no structured health program for T1DM which is implementable, deliverable, replicable, scalable and pharmaco-economically viable.6,7 We have embarked upon implementing a pilot model project for the management of T1DM in selected districts
No takes yet. Share an insight, caveat, or question.
Yasmin et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: